Senior insider sale
EVP, Chief Financial Officer at INTELLIA THERAPEUTICS, INC. — senior position signals high conviction
$80.6K
4.68K shares
What this filing means
DULAC EDWARD J III plans to sell 4.68K shares of INTELLIA THERAPEUTICS, INC. valued at approximately $80.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/2/2026ACC: 0001950047-26-006836
Officer· EVP, Chief Financial Officer
Since Mar 2026
4.68K
Shares to sell
$80.6K
Approx. market value
4.68K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
1/1/2026
4.68KTotal acquired4.68K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/1/2026 | Restricted Stock Units N/A | 4.68K | — |
| Total | 4.68K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
4.68K
Market value
$80.6K
7/2/2026
Total
Units
4.68K
Value
$80.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/2/2026 | 4.68K | $80.6K | NASDAQ | Planned |
| Total | 4.68K | $80.6K | ||